Macrolide resistance and emm type distribution of invasive pediatric group A streptococcal isolates: three-year prospective surveillance from a children's hospital
Clicks: 353
ID: 115779
2007
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
79.5
/100
349 views
281 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
In this group of 35 invasive GAS isolates, no cases of macrolide resistance were found. emm type 1 accounted for the highest percentage of invasive disease, followed by emm type 12. The type-specific GAS M protein-based vaccine currently in development includes the emm types of 33 of 35 (94%) of the …
| Reference Key |
p2007themacrolide
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Jaggi P;Beall B;Rippe J;Tanz RR;Shulman ST;; |
| Journal | the pediatric infectious disease journal |
| Year | 2007 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
Child
drug resistance
multiple
bacterial*
population surveillance
hospitals
anti-bacterial agents / pharmacology*
bacterial proteins / genetics
stanford t shulman
macrolides / pharmacology*
streptococcal infections / epidemiology
streptococcus pyogenes / drug effects*
streptococcal infections / microbiology*
pediatric
streptococcus pyogenes / metabolism
pmid:17484224
doi:10.1097/01.inf.0000256761.10463.29
preeti jaggi
bernard beall
bacterial proteins / metabolism*
streptococcus pyogenes / classification
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.